Keywords: morphotek, opens, european, sites, ph, ii, morab-009

Morphotek opens European sites for Ph II MORAb-009 study

Article | 01 September 2008

Print This

Japanese drugmaker Eisai's US subsidiary Morphotek says that it has opened clinical sites in the European Union as part of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in